A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status (Q34475037)

2 August 2017

1 reference

title

A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status (English)

1 reference

2 August 2017

1 reference

P Ken Gillman

1

1 reference

PubMed ID

16342227

2 August 2017

language of work or name

1 reference

1 March 2006

1 reference

2 August 2017

Human Psychopharmacology

1 reference

2 August 2017

21

1 reference

2 August 2017

2

1 reference

2 August 2017

117-125

1 reference

Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargyline- and harmaline-pretreated rats.

2 August 2017

1 reference

Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease

21 January 2018

1 reference

The biochemical, behavioral, and neurologic effects of high Ltryptophan intake in the rhesus monkey.

21 January 2018

1 reference

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

21 January 2018

1 reference

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor

21 January 2018

1 reference

Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes

21 January 2018

1 reference

The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial

21 January 2018

1 reference

Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

21 January 2018

1 reference

Meta-analytical studies on new antidepressants.

21 January 2018

1 reference

7 January 2021

Myoclonus and ocular oscillations induced by L-tryptophan

1 reference

7 January 2021

Serotonin syndrome with mirtazapine-fluoxetine combination

1 reference

7 January 2021

Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo.

1 reference

7 January 2021

Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine

1 reference

7 January 2021

The Serotonin Syndrome

1 reference

7 January 2021

Safety of mirtazapine in overdose

1 reference

7 January 2021

Prolactin response to tryptophan during mianserin treatment

1 reference

7 January 2021

The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission

1 reference

7 January 2021

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

1 reference

7 January 2021

Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers

1 reference

7 January 2021

Serotonin syndrome induced by fluvoxamine and mirtazapine

1 reference

7 January 2021

Serotonin syndrome produced by a combination of venlafaxine and mirtazapine

1 reference

7 January 2021

Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity

1 reference

7 January 2021

Safety in overdose of mirtazapine: a case report.

1 reference

7 January 2021

Successful treatment of serotonin syndrome with chlorpromazine

1 reference

7 January 2021

Serotonin syndrome treated with chlorpromazine

1 reference

7 January 2021

Serotonin syndrome: history and risk

1 reference

7 January 2021

The serotonin syndrome and its treatment

1 reference

7 January 2021

Comments on "Serotonin syndrome during treatment with paroxetine and risperidone".

1 reference

7 January 2021

Amitriptyline: dual-action antidepressant?

1 reference

7 January 2021

Mirtazapine: unable to induce serotonin toxicity?

1 reference

7 January 2021

Moclobemide and the risk of serotonin toxicity (or serotonin syndrome).

1 reference

7 January 2021

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

1 reference

7 January 2021

Animal models of serotonin behavior.

1 reference

7 January 2021

Dual action antidepressants and some important considerations

1 reference

7 January 2021

Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.

1 reference

7 January 2021

Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.

1 reference

7 January 2021

Severe serotonin syndrome induced by mirtazapine monotherapy.

1 reference

7 January 2021

Mirtazapine as treatment for serotonin syndrome.

1 reference

7 January 2021

Suicide attempts with mirtazapine overdose without complications.

1 reference

7 January 2021

Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine

1 reference

7 January 2021

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

1 reference

7 January 2021

The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment

1 reference

7 January 2021

Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity.

1 reference

7 January 2021

Adverse reactions to mirtazapine are unlikely to be serotonin toxicity

1 reference

7 January 2021

A risk-benefit assessment of mirtazapine in the treatment of depression

1 reference

7 January 2021

Comparative toxicity of citalopram and the newer antidepressants after overdose.

1 reference

7 January 2021

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

7 January 2021

Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine

1 reference

7 January 2021

The behavioural responses to 8-OH-DPAT, ipsapirone and the novel 5-HT1A receptor agonist Bay Vq 7813 in the pig.

1 reference

7 January 2021

Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders

1 reference

7 January 2021

Serotonin syndrome: early management with cyproheptadine

1 reference

7 January 2021

Neurochemical effects of the enantiomers of mirtazapine in normal rats

1 reference

7 January 2021

Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

1 reference

7 January 2021

Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.

1 reference

7 January 2021

Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome

1 reference

7 January 2021

Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome

1 reference

7 January 2021

Risperidone counteracts lethality in an animal model of the serotonin syndrome

1 reference

7 January 2021

Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

1 reference

7 January 2021

Poisoning severity score. Grading of acute poisoning

1 reference

7 January 2021

Mirtazapine overdose with benign outcome

1 reference

7 January 2021

Non-fatal mirtazapine overdose

1 reference

7 January 2021

The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat

1 reference

7 January 2021

Pharmacological principles of antidepressant efficacy

1 reference

7 January 2021

Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients

1 reference

7 January 2021

Endocrinological effects of mirtazapine in healthy volunteers

1 reference

7 January 2021

The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects

1 reference

7 January 2021

A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery.

1 reference

7 January 2021

Sleep-endocrine profile of the antidepressant mianserin

1 reference

7 January 2021

Dual monoamine modulation for improved treatment of major depressive disorder

1 reference

7 January 2021

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

7 January 2021

Mirtazapine-induced serotonin syndrome

1 reference

7 January 2021

Does mirtazapine enhance serotonergic neurotransmission in depressed patients?

1 reference

7 January 2021

Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.750

1 reference

2 August 2017

1 reference

PubMed ID

16342227